Skip to content
Disclosery

New Leaf Venture Partners, L.L.C.

Follow

13F filer, CIK 1631614, New York, NY

New Leaf Venture Partners, L.L.C. reported $97,295,291 across 10 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-011274

Period
2024-09-30
Reported value
$97.3M
Holdings
10
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ARVNadded+145,200$3.58M
ITRMFadded+247,934$270K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0000950123-24-011274, largest first. % of portfolio is the value over $97,295,292, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,553,661 shares; 2024Q1: 1,553,661 shares; 2024Q2: 1,553,661 shares; 2024Q3: 1,553,661 shares 1,553,661$41.5M42.62%0Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,289,521 shares; 2024Q1: 1,289,521 shares; 2024Q2: 1,289,521 shares; 2024Q3: 1,434,721 shares 1,434,721$35.3M36.32%+145,200Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 141,000 shares; 2024Q1: 141,000 shares; 2024Q2: 141,000 shares; 2024Q3: 141,000 shares 141,000$7.21M7.41%0Timeline
RALLYBIO CORPRALLYBIO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 3,301,603 shares; 2024Q1: 3,301,603 shares; 2024Q2: 3,301,603 shares; 2024Q3: 3,301,603 shares 3,301,603$3.86M3.97%0
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 118,242 shares; 2024Q1: 118,242 shares; 2024Q2: 150,706 shares; 2024Q3: 150,706 shares 150,706$2.78M2.86%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 250,765 shares; 2024Q1: 250,765 shares; 2024Q2: 250,765 shares; 2024Q3: 250,765 shares 250,765$2.71M2.78%0Timeline
PASSAGE BIO INCPASSAGE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,497,922 shares; 2024Q1: 2,497,922 shares; 2024Q2: 2,497,922 shares; 2024Q3: 2,497,922 shares 2,497,922$1.75M1.8%0
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 339,569 shares; 2024Q1: 339,569 shares; 2024Q2: 339,569 shares; 2024Q3: 339,569 shares 339,569$1.58M1.63%0Timeline
ITRMFITERUM THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 97,084 shares; 2024Q1: 97,084 shares; 2024Q2: 97,086 shares; 2024Q3: 345,020 shares 345,020$376K0.39%+247,934Timeline
X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 335,000 shares; 2024Q1: 335,000 shares; 2024Q2: 335,000 shares; 2024Q3: 335,000 shares 335,000$224K0.23%0

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-24-011274 base2024-11-13acceptance time not in the bulk data set